Skip to content

Platelet Aggregation Response To Factors in Patients Of occlusive Retinal Vein Disorders

Evaluation of Platelet Aggregation response to Epinephrine, Collagen and Ristocetin in patients of Retinal Vein Occlusion - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/073421
Enrollment
30
Registered
2024-09-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H348- Other retinal vascular occlusions

Interventions

Intervention1: NIL: NIL

Sponsors

Maulana Azad Medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of branch retinal vein occlusion, in the age range of 45-65 years 2. Patients having normal platelet count, prothrombin time and activated partial thromboplastin time

Exclusion criteria

Exclusion criteria: 1. Patients having other significant ocular diseases like glaucoma, media opacity, optic nerve disorders, high refractive errors, other significant co-existing retinal diseases especially those which affect macular perfusion (e.g. diabetic retinopathy, uveitis and vasculitis) 2. Patients having best corrected visual acuity lesser than 6/60 3. Patients on any anti-platelet-aggregating drugs, anticoagulants or non-steroidal anti-inflammatory drugs

Design outcomes

Primary

MeasureTime frame
Platelet aggregation response to agonists including epinephrine, collagen and ristocetin in patients of branch retinal vein occlusionTimepoint: 4 weeks

Secondary

MeasureTime frame
1. Optical coherence tomography angiography parameters (Foveal Avascular Zone, vessel density) & 2. Posterior segment Optical Coherence Tomography parameters (Central foveal thickness & sub- foveal choroidal thickness) Timepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Alok Kumar

Guru Nanak Eye Centre

alokrohilla99@gmail.com8059484067

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026